EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Physiological Barriers, System Design, and Applications in Disease Prevention and Treatment for Local mRNA Delivery to the Respiratory Tract

Longwei Xiang, Yunni You, Kai Hao, Huayu Tian

MedComm – Biomaterials and Applications · 2026-12 · 5 (4)

DOI: 10.1002/mba2.70083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Biomaterials and Applications, online erschienen am 16.11.2026. Verfasst von Longwei Xiang und 3 weiteren Autor:innen. Die Arbeit nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) therapies enable transient, controllable, and programmable protein expression without integrating into the host genome. However, pulmonary mRNA delivery remains constrained by airway deposition, mucociliary clearance, mucus entrapment, pulmonary surfactant interactions, extracellular nuclease degradation, nonspecific immune‐cell uptake, and inefficient endosomal escape. This review systematically examines local pulmonary mRNA delivery through a three‐tier barrier framework encompassing airway clearance, the alveolar microenvironment, and intracellular trafficking, and further discusses how disease‐specific pathological microenvironments remodel these barriers. We compare major non‐viral delivery platforms, including lipid nanoparticles, polymeric nanoparticles, liposomes, micelles, and extracellular vesicles, with emphasis on their molecular design, physicochemical properties, nebulization stability, mucus penetration, intracellular release, and translational limitations. Representative applications in protein replacement, mucosal vaccination, lung cancer immunotherapy, and inflammatory and fibrotic lung diseases are also summarized. Particular emphasis is placed on three interconnected dimensions: maintaining formulation stability during nebulization, adapting delivery systems to disease‐remodeled pulmonary barriers, and achieving cell‐selective mRNA delivery. Finally, we discuss pulmonary safety, repeated administration, disease‐relevant functional outcomes, and preclinical‐to‐clinical translation. By integrating barriers, carrier design, therapeutic applications, and translational considerations, this review provides a framework for the rational development of safe, reproducible, and clinically meaningful pulmonary mRNA therapies.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Xiang, L., You, Y., Hao, K., & Tian, H. (2026). Physiological Barriers, System Design, and Applications in Disease Prevention and Treatment for Local mRNA Delivery to the Respiratory Tract. MedComm – Biomaterials and Applications, 5(4). https://doi.org/10.1002/mba2.70083

Vancouver

Xiang L, You Y, Hao K, Tian H. Physiological Barriers, System Design, and Applications in Disease Prevention and Treatment for Local mRNA Delivery to the Respiratory Tract. MedComm – Biomaterials and Applications. 2026;5(4). doi:10.1002/mba2.70083

BibTeX
@article{Xiang2026,
  author = {Xiang, Longwei and You, Yunni and Hao, Kai and Tian, Huayu},
  title = {Physiological Barriers, System Design, and Applications in Disease Prevention and Treatment for Local mRNA Delivery to the Respiratory Tract},
  journal = {MedComm – Biomaterials and Applications},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.1002/mba2.70083}
}
Kostenlos starten →